HomeTagsConcept Medical

Concept Medical

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease

The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of...

Concept Medical granted Investigational Device Exemption approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee Arterial Disease

Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon.The Magic Touch...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics